SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-297865
Filing Date
2021-10-13
Accepted
2021-10-13 16:37:32
Documents
12
Period of Report
2021-10-10
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d211305d8k.htm   iXBRL 8-K 37588
  Complete submission text file 0001193125-21-297865.txt   163273

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA fdmt-20211010.xsd EX-101.SCH 2938
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE fdmt-20211010_lab.xml EX-101.LAB 18124
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fdmt-20211010_pre.xml EX-101.PRE 11436
5 EXTRACTED XBRL INSTANCE DOCUMENT d211305d8k_htm.xml XML 3414
Mailing Address 5858 HORTON STREET #455 EMERYVILLE CA 94608
Business Address 5858 HORTON STREET #455 EMERYVILLE CA 94608 5105052680
4D Molecular Therapeutics Inc. (Filer) CIK: 0001650648 (see all company filings)

IRS No.: 473506994 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39782 | Film No.: 211321638
SIC: 2836 Biological Products, (No Diagnostic Substances)